Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gilead Sciences Marketing Authorisation Application for Regadenoson Validated by European Medicines Agency
Gilead, 05/29/09

Gilead Sciences, Inc. announced that the company's Marketing Authorisation Application for regadenoson, an investigational pharmacologic stress agent for radionuclide myocardial perfusion imaging, was validated by the European Medicines Agency. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use for formal review to determine whether regadenoson is a safe and efficacious pharmacologic stress agent in humans.

Today in Marketing/Media/ROI...keeping you current

Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09

Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

 See all of Marketing/Media/ROI

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address